Induction of Immune Tolerance in Patients with Hemophilia and Inhibitors
Management of Inhibitors in Hemophilia
Prophylaxis in Hemophiliacs with Inhibitors
Genetics of Inhibitor Formation in Hemophilia
Other Languages Spoken
Nadia Ewing, M.D., is a clinical professor of Pediatrics and director of the Pediatric Hemophilia Treatment Center at City of Hope, where she also serves as director of the Sickle Cell Program and Pediatric Hematology Consultations. Dr. Ewing earned her medical degree at the University of Southern California (USC) in Los Angeles. She completed an internship and residency in pediatrics, followed by a fellowship in Pediatric Hematology/Oncology at the Los Angeles County/USC Medical Center.
Dr. Ewing is a member of the International Society on Thrombosis and Haemostasis, the Hemostasis and Thrombosis Research Society, the American Society of Hematology, The American Society of Pediatric Hematology/Oncology and the World Federation of Hemophilia. Her research interests include gene therapy in hemophilia, management of inhibitors in hemophilia, and genetics of inhibitor formation in hemophilia. She has written articles in The New England Journal of Medicine, the Journal of Pediatric Hematology/Oncology and Haemophilia. Dr. Ewing has presented abstracts for the American Society of Hematology, ISTH, and the Hemostasis and Thrombosis Research Society.